Reeve Emma 4
4 · PTC THERAPEUTICS, INC. · Filed Oct 7, 2025
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Exercise/Conversion
Common Stock
2025-10-03$39.42/sh+10,000$394,200→ 20,332 total - Sale
Common Stock
2025-10-03$66.10/sh−4,037$266,846→ 12,216 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-03−10,000→ 0 totalExercise: $33.63Exp: 2033-01-04→ Common Stock (10,000 underlying) - Sale
Common Stock
2025-10-03$66.87/sh−2,381$159,217→ 10,332 total - Sale
Common Stock
2025-10-03$65.02/sh−2,163$140,638→ 15,081 total - Sale
Common Stock
2025-10-03$66.93/sh−1,600$107,088→ 10,332 total - Exercise/Conversion
Common Stock
2025-10-03$33.63/sh+8,650$290,900→ 18,982 total - Sale
Common Stock
2025-10-03$65.05/sh−2,729$177,521→ 16,253 total - Sale
Common Stock
2025-10-03$66.09/sh−4,591$303,419→ 12,713 total - Exercise/Conversion
Common Stock
2025-10-03$33.02/sh+6,912$228,234→ 17,244 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-03−6,912→ 0 totalExercise: $33.02Exp: 2029-01-21→ Common Stock (6,912 underlying) - Sale
Common Stock
2025-10-03$65.09/sh−3,028$197,093→ 17,304 total - Sale
Common Stock
2025-10-03$66.11/sh−3,149$208,180→ 11,932 total - Sale
Common Stock
2025-10-03$66.89/sh−1,884$126,021→ 10,332 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-03−8,650→ 0 totalExercise: $33.63Exp: 2028-12-13→ Common Stock (8,650 underlying)
Footnotes (11)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.
- [F10]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.61 to $67.28 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F11]Currently exercisable.
- [F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.50 to $65.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.50 to $66.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.50 to $67.29 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.50 to $65.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.50 to $66.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.61 to $67.33 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F8]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.50 to $65.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F9]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.50 to $66.46 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.